Abstract 68P
Background
Glioblastomas are grade IV gliomas of the central nervous system associated with a median survival rate of less than 15 months. Therefore, research has been focused on better understanding the role of the tumor immune microenvironment, specifically macrophages (tissue-resident and monocyte-derived), which make up to 30% of the tumour. Using imaging mass cytometry, we have demonstrated that long-term survival in glioblastoma is associated with an accumulation of a rare subset of MPO+ monocyte-derived macrophages (MDM) within tumors, which appeared to originate from a shift in monocytosis. Transcriptomics analyses revealed that these macrophages exhibited heightened effector functions, potentially explaining their association with prolonged survival. This raises the question of whether monocyte developmental trajectories can be targeted as a therapeutic approach to promote the accumulation of MDM with elevated MPO, by reprogramming progenitor cells systemically.
Methods
To elucidate the effects of progenitor reprogramming on changes in the macrophage compartment, stimulants of myelopoiesis were administered. Bone marrow, blood, and spleen were characterized using flow cytometry. Furthermore, utilizing genetic and transplantable mouse models of glioblastoma (RCAS PDGFB-ink4a model and the GL261 model), durable reprogramming was induced, and tumor progression was assessed using MRI.
Results
In tumor-bearing and non-tumor-bearing mice, myelopoiesis was successfully reprogrammed as depicted in blood by increased proportions of Ly6C+ monocytes expressing high levels of TNF-α, IL-10, MPO, and CCR2. Similar changes were observed in the spleens of non-tumor-bearing mice. Studies using mouse models of glioblastoma indicated changes in survival and tumor volumes following progenitor reprogramming.
Conclusions
Systemic reprogramming of the myeloid compartment could have beneficial effects in preclinical models of glioblastoma.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Canadian Institutes of Health Research (CIHR).
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
62P - Role of IL6 (C-174G) polymorphism in the development of cervical intraepithelial neoplasia
Presenter: Tatyana Abakumova
Session: Cocktail & Poster Display session
Resources:
Abstract
63P - The impact of disruption of melatonin secretion on the structural-functional changes of the microbiome and the role of the melatonin-microbiome axis in the initiation of carcinogenesis
Presenter: Alexandre Tavartkiladze
Session: Cocktail & Poster Display session
Resources:
Abstract
64P - Acidosis induces ferroptosis of breast cancer via ZFAND5/SLC3A2 axis with the synergistic effect of metformin and facilitates M1 macrophage polarization
Presenter: Hanchu Xiong
Session: Cocktail & Poster Display session
Resources:
Abstract
65P - Transmembrane distribution of phosphatidylethanolamine in plasma membrane of ovarian cancer cells under conditions mimicking tumor microenvironment
Presenter: Darya Savenkova
Session: Cocktail & Poster Display session
Resources:
Abstract
66P - Metabolic regulation of GMP- and MDP-derived macrophages in glioblastoma
Presenter: Liam Wilson
Session: Cocktail & Poster Display session
Resources:
Abstract
67P - Inflammation status and sarcopenia synergistically impact outcomes in cancer patients (pt) treated with ImmunOtherapy (IO) within the framework of a Molecular Pre-screening program (MP) and a spEcial Medication (ME) program
Presenter: Lucia Notario Rincon
Session: Cocktail & Poster Display session
Resources:
Abstract
69P - Integrated OMIC analysis reveals arginine and proline metabolism plays critical role in hypoxia-induced oral squamous cell carcinoma
Presenter: Avinash Singh
Session: Cocktail & Poster Display session
Resources:
Abstract
70P - Individualising methotrexate dose based on MTHFR gene polymorphisms in acute lymphoblastic leukemia
Presenter: Meher Konatam
Session: Cocktail & Poster Display session
Resources:
Abstract
71P - Single nucleotide polymorphisms in the folate metabolic pathway genes and global DNA methylation in ovarian cancer
Presenter: Sandro Surmava
Session: Cocktail & Poster Display session
Resources:
Abstract
72P - Role of pyruvate carboxykinase 2 upregulation in group 3 medulloblastoma: Implications for metabolic reprogramming and therapeutic strategies
Presenter: MEDHA GAYATHRI PAI
Session: Cocktail & Poster Display session
Resources:
Abstract